US 11,814,645 · Application 17/220,693 · Granted Nov 14, 2023
US 11,814,645
Methods and compositions for rna-directed target dna modification and for rna-directed modulation of transcription
Estimated expiration
March 15, 2033
6y 168d remaining
Earliest effective filing
Mar 15, 2013
+ 20 years
Mar 15, 2033
PTA +234d
Nov 4, 2033
TD cap (US 10,301,651)
Mar 15, 2033
Final
Mar 15, 2033
This calculation includes patent term adjustment (PTA) under 35 U.S.C. §154(b). Patent term extension (PTE) under 35 U.S.C. §156 (for FDA-regulated products) is not included. Terminal disclaimers can affect PTA (In re Cellect, LLC).
Calculation details
Base term
- Filing date
- April 1, 2021
- Earliest effective filing
- March 15, 2013
- Issue date
- November 14, 2023
- PTA
- +234 days
- Base expiry (before PTA)
- March 15, 2033
March 15, 2013 + 20 years = March 15, 2033 + 234 PTA days = November 4, 2033
- Continuation of application 16/385,360, filed Apr 16, 2019
- Continuation of application 13/842,859, filed Mar 15, 2013, issued as US 10,266,850
- Continuation of application 13/842,859, filed Mar 15, 2013, issued as US 10,266,850
- PRO61/652,086 — Provisional — not used for base term
- PRO61/716,256 — Provisional — not used for base term
- PRO61/757,640 — Provisional — not used for base term
- PRO61/765,576 — Provisional — not used for base term
- PRO61/765,576 — Provisional — not used for base term
- PRO61/757,640 — Provisional — not used for base term
- PRO61/716,256 — Provisional — not used for base term
- PRO61/652,086 — Provisional — not used for base term
- PRO61/765,576 — Provisional — not used for base term
- PRO61/757,640 — Provisional — not used for base term
- PRO61/716,256 — Provisional — not used for base term
- PRO61/652,086 — Provisional — not used for base term
Terminal disclaimers
TD caps expiration to March 15, 2033 (earliest expiring referenced patent: US 10,301,651)
US 10,301,651· Application 14/685,504Capping patent
Methods and compositions for rna-directed target dna modification and for rna-directed modulation of transcription
- Filing date
- Apr 13, 2015
- Earliest effective filing
- Mar 15, 2013
- Issue date
- May 28, 2019
- PTA
- 0 days
- Calculated expiration
- Mar 15, 2033
Continuation of 13/842,859, filed Mar 15, 2013, issued as US 10,266,850
Mar 15, 2013 + 20y = Mar 15, 2033
US 10,308,961· Application 16/033,016
Methods and compositions for rna-directed target dna modification and for rna-directed modulation of transcription
- Filing date
- Jul 11, 2018
- Earliest effective filing
- Mar 15, 2013
- Issue date
- Jun 4, 2019
- PTA
- 0 days
- Calculated expiration
- Mar 15, 2033
Continuation of 13/842,859, filed Mar 15, 2013, issued as US 10,266,850
Mar 15, 2013 + 20y = Mar 15, 2033
US 10,640,791· Application 16/276,352
Methods and compositions for rna-directed target dna modification and for rna-directed modulation of transcription
- Filing date
- Feb 14, 2019
- Earliest effective filing
- Mar 15, 2013
- Issue date
- May 5, 2020
- PTA
- 0 days
- Calculated expiration
- Mar 15, 2033
Continuation of 13/842,859, filed Mar 15, 2013, issued as US 10,266,850
Mar 15, 2013 + 20y = Mar 15, 2033
US 11,814,645· Application 17/220,693(from application 17/220,693)
Methods and compositions for rna-directed target dna modification and for rna-directed modulation of transcription
- Filing date
- Apr 1, 2021
- Earliest effective filing
- Mar 15, 2013
- Issue date
- Nov 14, 2023
- PTA
- +234 days
- Calculated expiration
- Nov 4, 2033
Continuation of 16/385,360, filed Apr 16, 2019
Continuation of 13/842,859, filed Mar 15, 2013, issued as US 10,266,850
Continuation of 13/842,859, filed Mar 15, 2013, issued as US 10,266,850
Mar 15, 2013 + 20y + 234d PTA = Nov 4, 2033
Notes (1)
- [TD_DOCS_TRUNCATED] Found 6 filed TD documents; parsing first 3 only
Patent term extension under 35 U.S.C. §156, which can apply to certain drug, biologic, animal drug and medical device patents, is not included in this calculation. How PTE is calculated
The prosecution record for your AI
Application 17/220,693 · US 11,814,645
You have the date. Your AI can have the file.
PatentReply compiles the prosecution history behind US 11,814,645: the claims as filed and as allowed, every Office Action and response, and the cited references, with each answer pointing back to the filed passage.
One new public application a month is free. The first compile takes a few minutes.
Strategy and filing changes require your approval.
Permanent link
www.patentreply.ai/tools/patent-expiration/US11814645Data sourced from public USPTO records. This tool provides informational estimates and should not be relied upon as legal advice. Always verify patent expiration dates independently, especially where patent term extension, terminal disclaimers, or unusual continuity issues may apply.